| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8210989 | International Journal of Radiation Oncology*Biology*Physics | 2018 | 46 Pages |
Abstract
In adult patients with early-stage HL without risk factors in complete remission after epirubicin, bleomycin, vinblastine, and prednisone chemotherapy, the RT dose may be limited to 20Â Gy without compromising disease control. Omitting RT in these patients may jeopardize the treatment outcome.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
José MD, Christophe MD, Evert M. MD, Franck MD, Théodore MD, Isabelle MD, Pieternella J. MD, Marc MD, Marnix L.M. MD, Aspasia MD, Max MD, Philippe MD, Houchingue MD, Jean MD, Richard W.M. MD, Jérôme MD, Krimo MD, Olivier MD, Michel MD,